ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Immunogenicity of Peru-15 Vaccine When Given With Measles Vaccine in Healthy Indian and Bangladeshi Infants

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00624975
Recruitment Status : Terminated (one of site was not able to get an approval from the national regulatory authority.)
First Posted : February 28, 2008
Last Update Posted : August 1, 2012
Sponsor:
Collaborators:
International Centre for Diarrhoeal Disease Research, Bangladesh
Christian Medical College, Vellore, India
Avant Immunotherapeutics
Vaccine Technologies Inc.
Information provided by (Responsible Party):
International Vaccine Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : July 2012
  Actual Study Completion Date : July 2012